A current patient reveals valuable insights about this unique treatment.
— Read on www.psychologytoday.com/au/blog/mind-tapas/201910/ketamine-saved-my-life
Monthly Archives: December 2022
HMNC aims to make ketamine treatment first-in-class for patients
Chief clinical development officer of HMNC Brain Health, Hans Eriksson, speaks to Psychedelic Health about how the company’s formula, ‘Ketabon’, will provide the therapeutic benefits of ketamine without the ‘trip.’
— Read on psychedelichealth.co.uk/2022/10/03/hmnc-ketamine-treatment-first-class-patients/amp/
Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis. – PsycNET
APA PsycNet DoiLanding page
— Read on psycnet.apa.org/
Ketamine Leadership Academy 
You must be logged in to post a comment.